United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Apr 8, 2026 · Filed Apr 9, 2026

On Apr 8, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$580.45 for US$5.51M under a trading plan, leaving 40,513 shares. Filed Apr 9, 2026 (Form 4).

Sold
9,500 shares
Price
US$580.45 average (US$565.38 to US$585.48)
Value
US$5.51M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 8, 2026Common StockOption exercise9,500US$146.0350,013Direct
Apr 8, 2026Common StockSale225US$565.3849,788Direct
Apr 8, 2026Common StockSale15US$566.0049,773Direct
Apr 8, 2026Common StockSale360US$568.7449,413Direct
Apr 8, 2026Common StockSale120US$572.1249,293Direct
Apr 8, 2026Common StockSale520US$575.8648,773Direct
Apr 8, 2026Common StockSale560US$577.0748,213Direct
Apr 8, 2026Common StockSale600US$578.0847,613Direct
Apr 8, 2026Common StockSale480US$579.2247,133Direct
Apr 8, 2026Common StockSale477US$580.5946,656Direct
Apr 8, 2026Common StockSale1,337US$581.7245,319Direct
Apr 8, 2026Common StockSale2,166US$582.4943,153Direct
Apr 8, 2026Common StockSale1,874US$583.4441,279Direct
Apr 8, 2026Common StockSale486US$584.4740,793Direct
Apr 8, 2026Common StockSale280US$585.4840,513Direct

Source

View original at SEC

Related